Cargando…

Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD

INTRODUCTION: Clinical decisions in chronic obstructive pulmonary disease (COPD) treatment often utilize serially assessed physiologic parameters and biomarkers. To better understand the reliability of these tests, we evaluated changes in commonly assessed biomarkers over 3 months in patients with c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Seon Cheol, Saiphoklang, Narongkorn, Phillips, Jonathan, Wilgus, May-Lin, Buhr, Russell G, Tashkin, Donald P, Cooper, Christopher B, Barjaktarevic, Igor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362903/ https://www.ncbi.nlm.nih.gov/pubmed/37485051 http://dx.doi.org/10.2147/COPD.S396549

Ejemplares similares

Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity
por: Park, Seon-Cheol, et al.
Publicado: (2022)

Correlation between Hand Grip Strength and Peak Inspiratory Flow Rate in Patients with Stable Chronic Obstructive Pulmonary Disease
por: Suriyakul, Apisara, et al.
Publicado: (2022)

Bronchodilator responsiveness or reversibility in asthma and COPD – a need for clarity
por: Barjaktarevic, Igor, et al.
Publicado: (2018)

Incidence and outcome of weaning from mechanical ventilation in medical wards at Thammasat University Hospital
por: Saiphoklang, Narongkorn, et al.
Publicado: (2018)

Eosinophilia and parasitic infestations in patients with chronic obstructive pulmonary disease
por: Saiphoklang, Narongkorn, et al.
Publicado: (2020)

Handgrip strength cutoff value predicting successful extubation in mechanically ventilated patients
por: Saiphoklang, Narongkorn, et al.
Publicado: (2021)

Correlation between Handgrip Strength and Rapid Shallow Breathing Index for Assessment of Weaning from Mechanical Ventilation
por: Saiphoklang, Narongkorn, et al.
Publicado: (2021)

Factors influencing acceptance of influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease
por: Saiphoklang, Narongkorn, et al.
Publicado: (2022)

How Differential Are the Effects of Smoking Cannabis versus Tobacco on Lung Function?
por: Tashkin, Donald P., et al.
Publicado: (2022)

Marijuana Use as a Risk Factor for Chronic Obstructive Pulmonary Disease: Not There Yet
por: Tashkin, Donald P., et al.
Publicado: (2023)

Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis
por: Shover, Carolyn M., et al.
Publicado: (2022)

Smoking characteristics and lung functions among university athletes
por: Saiphoklang, Narongkorn, et al.
Publicado: (2020)

Prediction of optimal continuous positive airway pressure in Thai patients with obstructive sleep apnea
por: Saiphoklang, Narongkorn, et al.
Publicado: (2021)

Comparison between 20 and 30 meters in walkway length affecting the 6-minute walk test in patients with chronic obstructive pulmonary disease: A randomized crossover study
por: Saiphoklang, Narongkorn, et al.
Publicado: (2022)

The Effect of Nintedanib in Post-COVID-19 Lung Fibrosis: An Observational Study
por: Saiphoklang, Narongkorn, et al.
Publicado: (2022)

Chronic Obstructive Pulmonary Disease is Not Associated with In-Hospital Mortality in COVID-19: An Observational Cohort Analysis
por: Toppen, William, et al.
Publicado: (2022)

The use of nebulized pharmacotherapies during the COVID-19 pandemic
por: Sethi, Sanjay, et al.
Publicado: (2020)

Positioning new pharmacotherapies for COPD
por: Barjaktarevic, Igor Z, et al.
Publicado: (2015)

Patient characteristics and outcomes of a home mechanical ventilation program in a developing country
por: Saiphoklang, Narongkorn, et al.
Publicado: (2019)

Smoking cessation in COPD: confronting the challenge
por: Tashkin, Donald P.
Publicado: (2021)

A review of nebulized drug delivery in COPD
por: Tashkin, Donald P
Publicado: (2016)

Eosinophil Recovery in Hospitalized COVID-19 Patients is Associated with Lower Rates of ICU Admission and In-Hospital Mortality: An Observational Cohort Analysis
por: Yan, Peter D., et al.
Publicado: (2023)

Nebulized Therapies in COPD: Past, Present, and the Future
por: Barjaktarevic, Igor Z, et al.
Publicado: (2020)

Preventing and managing exacerbations in COPD – critical appraisal of the role of tiotropium
por: Tashkin, Donald P
Publicado: (2010)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

Long-term variability of impulse oscillometry and spirometry in stable COPD and asthma
por: Xu, Jianhua, et al.
Publicado: (2022)

Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD
por: Tashkin, Donald P., et al.
Publicado: (2021)

Tiotropium HandiHaler(®) in the treatment of COPD: A safety review
por: Kesten, Steven, et al.
Publicado: (2009)

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis
por: Barjaktarevic, Igor Z, et al.
Publicado: (2019)

Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis
por: Halpin, David MG, et al.
Publicado: (2015)

Acute kidney injury in stable COPD and at exacerbation
por: Barakat, MF, et al.
Publicado: (2015)

Variability in objective and subjective measures affects baseline values in studies of patients with COPD
por: Anderson, Wayne H., et al.
Publicado: (2017)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate
por: Tashkin, Donald P, et al.
Publicado: (2021)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
por: Yoon, Jung-Ki, et al.
Publicado: (2020)

Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels
por: Weiss, Daniel J., et al.
Publicado: (2021)

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
por: Hanania, Nicola A, et al.
Publicado: (2011)

The association between eosinophilic exacerbation and eosinophilic levels in stable COPD
por: Kang, Hye Seon, et al.
Publicado: (2021)

Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD
por: Aaron, Shawn D, et al.
Publicado: (2010)

Comparison of the variability of the annual rates of change in FEV(1) determined from serial measurements of the pre- versus post-bronchodilator FEV(1) over 5 years in mild to moderate COPD: Results of the lung health study
por: Tashkin, Donald P, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v05lks9uns5pvbci95lnc3ge8k